PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

2-ethylhexyl (2E)-3-(4-methoxyphenyl)acrylate

EC / List no: 629-661-9 CAS no: 83834-59-7
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Testing Proposal
Status
Concluded
Decision date
07-ruj-2022
Decision
Latest update
09-svi-2024
Additional information
More information View
DEv 2
Scope
Testing Proposal
Status
Decision date
Decision
Latest update
22-ruj-2021
Additional information
More information View
DEv 3
Scope
Targeted
Status
Concluded
Decision date
10-lis-2013
Decision
Latest update
26-stu-2022
Additional information
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Germany
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Year
2016
Status
Concluded
Conclusion document
Latest update
15-stu-2023
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Germany
Status
Concluded
Outcome
inconclusive
Hazard assessment outcome document
Remarks
The overall data is insufficient to conclude on ED ENV properties of OMC.
However, based on considerations of proportionality, further data have
not been requested by the eMSCA to clarify the remaining concern. Data
requested and subsequently provided in the substance evaluation of the
structural analogue substance IPMC, may contribute to the clarification
of the concern about the ED properties of OMC.

(EC: 275-702-5 and 629-661-9) due to the indication of structural similarity of these substances, there may be a (potential) joined evaluation of these substances.
Concern
Endocrine disruption
Date of intention
13-ruj-2016
Date of hazard assessment
31-lis-2023
Latest update
23-stu-2023
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Opinion Development
Date of intention
21-kol-2023
Withdrawal date
Submitter
Germany
Proposed harmonised classification by the dossier submitter
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=10
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=10
Remarks
Date of opinion
RAC Opinion
Latest update
27-svi-2024
More information View

List entry date: 14-sij-2016

Export search results to: